A comparison of the apoptotic effect of Δ9-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex

Brain Research

Volumn 1175, Issue 1, 2007, Pages 39-47

  Downer, Eric J ^a   Gowran, Aoife ^a   Campbell, Veronica A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

9 Tetrahydrocannabinol; Apoptosis; Caspase 3; Cathepsin; Development

Indexed keywords

CASPASE 3; DRONABINOL; PROTEINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN SLICE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASE 3; CATHEPSIN D; CELLS, CULTURED; CEREBRAL CORTEX; COGNITION DISORDERS; DNA FRAGMENTATION; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; NERVE DEGENERATION; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

CANNABIS; CANNABIS SATIVA; RATTUS;

EID: 34848875379     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.076     Document Type: Article

References (38)

1. Antonelli T., Tomasini M.C., Tattoli M., Cassano T., Tanganelli S., Finetti S., and Mazzoni E. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes leaning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cerebral cortex 15 (2005) 2013-2020
2. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., and Fernández-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33 3 (1999) 181-191
3. Campbell V.A. Tetrahydrocannabinol-induced apoptosis in cultured cortical neurones is associated with cytochrome c release and caspase-3 activation. Neuropharmacology 40 (2001) 702-709
4. 9-tetrahydrocannabinol. J. Neurosci. 18 14 (1998) 5322-5332
5. 1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br. J. Pharm. 140 (2003) 547-557
6. Downer E.J., Gowran A., Murphy A.C., and Campbell V.A. The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons. Eur. J. Pharmacol. 564 (2007) 57-65
7. Fernández-Ruiz J., Berrendero F., Hernandez M.L., and Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23 (2000) 14-20
8. Fried P.A., and Smith A.M. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol. Teratol. 23 (2001) 1-11
9. Galve-Roperh I., Sánchez C., Luisa Cortes M., Gómez del Pulgar T., Izquierdo M., and Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6 (2000) 313-319
10. 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend. 42 (1996) 155-166
11. 9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res. 1128 (2007) 61-69
12. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8268-8273
13. 1 receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. J. Neurochem. 82 (2002) 154-158
14. Harkany T., Guzmán M., Galve-Roperh I., Berghuis P., Devi L.A., and Mackie K. The emerging functions of endocdannabinoid signalling during CNS development. Trends Pharmacol. Sci. 28 (2007) 83-92
15. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
16. Kågedal K., Johansson A.C., Johansson U., Heinmlich G., Roberg K., Wang N.S., Jürgensmeier J.M., and Ollinger K. Lysosomal membrane permeabilization during apoptosis-involvement of Bax?. Int. J. Exp. Pathol. 86 (2005) 309-321
17. Lawston J., Borella A., Robinson J.K., and Whitaker-Azmitia P.M. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2. Brain Res. 877 (2000) 407-410
18. Lyman W.D., Sonett J.R., Brosnan C.F., Elkin R., and Bornstein M.B. Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. Neuroimmunology 23 (1989) 73-81
19. Mailleux P., and Vanderhaeghen J.-J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 (1992) 655-668
20. Mato S., Del Olmo E., and Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur. J. Neurosci. 17 (2003) 1747-1754
21. Matochik J.A., Eldreth D.A., Cadet J.L., and Bolla K.I. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 77 (2005) 23-30
22. Matveyeva M., Hartmann C.B., Harrison M.T., Cabral G.A., and McCoy K.L. Delta (9)-tetrahydrocannabinol selectively increases aspartyl cathepsin D proteolytic activity and impairs lysozyme processing by macrophages. Int. J. Immunopharmacol. 22 (2000) 373-381
23. Mereu G., Fa M., Ferraro L., Cagiano R., Antonelli T., Tattoli M., Ghiglieri V., Tanganelli S., Gesssa G.L., and Cuomo V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. USA 100 (2003) 4915-4920
24. Navarro M., Rubio P., and de Fonseca F.R. Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology 122 (1995) 1-14
25. Raman C., McAllister S.D., Rizvi G., Patel S.G., Moore D.H., and Abood M.E. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 5 (2004) 33-39
26. Rodriguez de Fonseca F., Ramos J.A., Bonnin A., and Fernández-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4 (1993) 135-138
27. Rodríquez de Fonseca F., Hernández M.L., de Miguel R., Fernández-Ruiz J.J., and Ramos J.A. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids. Pharmacol. Biochem. Behav. 41 (1992) 469-474
28. Sarne Y., and Mechoulam R. Cannabinoids: between neuroprotection and neurotoxicity. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 677-684
29. Scallet A.C. Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol. Biochem. Behav. 40 (1991) 671-676
30. Schestkowa O, Geisel D, Jacob R, Hasilik A., 2007. The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells. J. Cell Biochem. 101, 1558-1566.
31. Schiaepfer T.E., Lancaster E., Heidbreder R., Strain E.C., Kosel M., Fisch H.U., and Pearlson G.D. Decreased frontal white-matter volume in chronic substance abuse. Drug Alcohol Depend. 77 (2006) 23-30
32. Sinor A.D., Irvin S.M., and Greenberg D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 278 (2000) 157-160
33. Smith A.M., Fried P.A., Hogan M.J., and Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol. Teratol. 28 (2006) 286-295
34. Suarez I., Bodega G., Rubio M., Fernandez-Ruiz J.J., Ramos J.A., and Fernandez B. Prenatal cannabinoid exposure down-regulates glutamate transporter expressions (GLAST and EAAC1) in the rat cerebellum. Dev. Neurosci. 26 (2004) 45-53
35. Szoke E., Czéh G., Szolcsányi J., and Seress L. Neonatal anandamide treatment in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. Neuroscience 115 (2002) 805-814
36. 1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
37. 9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J. Neurosci. 21 (2001) 6475-6479
38. Zuzarte-Luis V., Montero J.A., Torre-Perez N., Garcia-Porrero J.A., and Hurle J. Cathepsin D gene expression outlines the areas of physiological cell death during embryonic development. Dev. Dyn. 236 (2007) 330-335